Sharescart Research Club logo

Star Imaging & Path Overview

Star Imaging and Path Lab Ltd is a Delhi‑based diagnostics company that traces its roots to 1978, when it began as a small X‑ray and basic pathology clinic (under the name “Janta X‑Ray Clinic”). Over time the business expanded and in 2004 it was re‑established as a private company to offer a broad range of diagnostic services — radiology (X‑rays, CT scans, MRI, ultrasound, mammography, etc.), pathology (biochemistry, microbiology, histopathology, etc.), cardiology, neurology and related clinical lab testing — all under one roo...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Star Imaging & Path Key Financials

Market Cap ₹139 Cr.

Stock P/E 8.7

P/B 1.2

Current Price ₹80

Book Value ₹ 66.4

Face Value 10

52W High ₹152

Dividend Yield 0%

52W Low ₹ 46

Star Imaging & Path Share Price

| |

Volume
Price

Star Imaging & Path Quarterly Price

Show Value Show %

Star Imaging & Path Peer Comparison

Star Imaging & Path Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Star Imaging & Path Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 69 59 79 84
Other Income 0 0 1 0
Total Income 69 59 80 84
Total Expenditure 54 52 56 55
Operating Profit 15 6 24 29
Interest 2 2 2 3
Depreciation 4 3 5 5
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 9 1 16 21
Provision for Tax 3 0 4 5
Profit After Tax 6 1 12 16
Adjustments -0 -0 -0 -0
Profit After Adjustments 6 1 12 16
Adjusted Earnings Per Share 4.7 0.4 9.2 11.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 6% 7% 0% 0%
Operating Profit CAGR 21% 25% 0% 0%
PAT CAGR 33% 39% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 41% 31% 32% 32%
ROCE Average 34% 25% 25% 25%

Star Imaging & Path Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 18 19 31 47
Minority's Interest 0 0 0 0
Borrowings 17 14 16 15
Other Non-Current Liabilities 2 2 2 2
Total Current Liabilities 21 26 33 34
Total Liabilities 58 61 82 98
Fixed Assets 15 13 22 21
Other Non-Current Assets 12 22 7 10
Total Current Assets 32 26 53 67
Total Assets 58 61 82 98

Star Imaging & Path Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 6 9 2 16
Cash Flow from Operating Activities 14 5 18 -6
Cash Flow from Investing Activities -4 -7 -7 -4
Cash Flow from Financing Activities -7 -5 2 -0
Net Cash Inflow / Outflow 3 -7 13 -10
Closing Cash & Cash Equivalent 9 2 16 5

Star Imaging & Path Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.66 0.43 9.2 11.8
CEPS(Rs) 7.27 2.91 13.11 15.49
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 13.6 14.03 23.22 34.93
Core EBITDA Margin(%) 21.24 10.32 28.73 34.31
EBIT Margin(%) 16.4 4.87 23.59 28.72
Pre Tax Margin(%) 13.59 1.52 20.46 25.67
PAT Margin (%) 9.11 1 15.81 19.11
Cash Profit Margin (%) 14.21 6.71 22.46 25.05
ROA(%) 10.79 0.98 17.43 17.75
ROE(%) 34.28 3.13 49.53 40.65
ROCE(%) 23.64 6.1 34.58 33.81
Receivable days 85.39 105.29 116.4 182.27
Inventory Days 0.4 2.21 2.69 1.68
Payable days 130.08 364.68 504.94 547.66
PER(x) 0 0 0 0
Price/Book(x) 0 0 0 0
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.32 0.44 0.21 0.49
EV/Core EBITDA(x) 1.48 4.15 0.69 1.41
Net Sales Growth(%) 0 -15.28 34.6 5.99
EBIT Growth(%) 0 -74.86 552.4 29.06
PAT Growth(%) 0 -90.74 2036.52 28.12
EPS Growth(%) 0 -90.8 2045.1 28.26
Debt/Equity(x) 1.61 1.4 0.98 0.69
Current Ratio(x) 1.48 1.01 1.63 1.97
Quick Ratio(x) 1.48 0.98 1.61 1.96
Interest Cover(x) 5.83 1.45 7.54 9.4
Total Debt/Mcap(x) 0 0 0 0

Star Imaging & Path Shareholding Pattern

# Jun 2025 Aug 2025 Sep 2025 Mar 2026
Promoter 71.92 71.92 71.92 71.92
FII 1.18 1.18 1.37 0.61
DII 10.77 10.77 8.73 5.1
Public 16.13 16.13 17.99 22.38
Others 0 0 0 0
Total 100 100 100 100

Star Imaging & Path News

Star Imaging & Path Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 31%
  • Company has reduced debt.

Cons

  • Debtor days have increased from 504.94 to 547.66days.
whatsapp